FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077414 [Registered on: 27/11/2024] Trial Registered Prospectively
Last Modified On: 25/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Study The Efficacy Of GokshurkadiChurna In Management Of Mutrashmari 
Scientific Title of Study   Randomized Controlled Clinical Trial To Study The Efficacy Of GokshurakadiChurna In Management Of Mutrashmari  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Niraj Vitthalrao Adhe 
Designation  PG Scholar MS Shalyatantra  
Affiliation  MES Ayurved Mahavidyalaya  
Address  Second floor, Shalyatantra department, PG Section, MES Ayurved Mahavidyalaya, Ghanekhunt Lote, Khed,Ratnagiri

Ratnagiri
MAHARASHTRA
415722
India 
Phone  9309727402  
Fax    
Email  adheniraj@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashok Devidas Pawar 
Designation  Associate Professor  
Affiliation  MES Ayurved Mahavidyalaya  
Address  Second floor, Shalyatantra department, PG Section, MES Ayurved Mahavidyalaya, Ghanekhunt Lote, Khed,Ratnagiri

Ratnagiri
MAHARASHTRA
415722
India 
Phone  9822285836  
Fax    
Email  dr.ashok2575@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Niraj Vitthalrao Adhe 
Designation  PG Scholar MS Shalyatantra  
Affiliation  MES Ayurved Mahavidyalaya  
Address  Second floor, Shalyatantra department, PG Section, MES Ayurved Mahavidyalaya, Ghanekhunt Lote, Khed,Ratnagiri

Ratnagiri
MAHARASHTRA
415722
India 
Phone  9309727402  
Fax    
Email  adheniraj@gmail.com  
 
Source of Monetary or Material Support  
MES Ayurved Mahavidyalaya & attached Parshuram Hospital & Research Center, Ghanekhunt Lote, Khed, Ratnagiri, Maharashtra, India-415722. 
 
Primary Sponsor  
Name  Dr Niraj Vitthalrao Adhe  
Address  MES Ayurved Mahavidyalaya, Ghanekhunt Lote, Khed, Ratnagiri,415722 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Niraj Vitthalrao Adhe   MES Parshuram Hospital   Department of Shalyatantra ,OPD No 1, Parshuram Hospital, Ghanekhunt Lote,Khed. Ratnagiri MAHARASHTRA
Ratnagiri
MAHARASHTRA 
9309727402

adheniraj@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MES AYURVED MAHAVIDYALAYA ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N22||Calculus of urinary tract in diseases classified elsewhere. Ayurveda Condition: MUTRAVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gokshurkadi churna, Reference: Harit Samhita 31 St chapter , Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -mahishdugdha), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Pashanbhed churna, Reference: Ashtanga sangraha sutrasthan chapter number 15, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -jaal), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients Having Signs And Symptoms Of Mutrashmari.
2) Patients Of Both Sex Will Be Included.
3) Patients Between Age Group 18 To 60 Year Will Be Included .
4) Calculus Of Size Up To 12mm Without Any Residual Complications.
5) Presence Of Stone In Any Location Of Urinary Tract. 
 
ExclusionCriteria 
Details  1) Pyonephrosis, Ca Of Urinary Tract.
2) Severe Haematuria.
3) Having Calculus Of Size More Than 12 Mm
4) Pregnant And Lactating Women.
5) Obstructive Uropathy Leading To Gross Hydro Nephrosis, Renal Function Impairment.
6) Known Patients Of Dm, Uncontrolled Htn,Hypotension Systemic Disease Like Tb, Hiv-Positive, Cardiovascular Disorders And Other Major Systemic Illness. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The Efficacy Of Gokshurkadi Churna In The Management Of Mutrashmari.  21 days study with follow up on 1st 7th 14th 21st day 
 
Secondary Outcome  
Outcome  TimePoints 
1.To Find Out Whether This Drug Reduces The Size Of Mutrashmari Or Promotes Its Expulsion.
2. To Establish The Better Medicinal Alternative In The Management Of Mutrashmari.
3.To Find Out Its Effect On The Symptoms Of Mutrashmari.
4.To Find Out Whether This Drug Shortens The Duration Of Treatment Of Mutrashmari Than Other Drug. 
21 days study with follow up on 1st 7th 14th 21st day  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [adheniraj@gmail.com].

  6. For how long will this data be available start date provided 20-11-2024 and end date provided 20-12-2030?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Title A Randomized Control Clinical Trial to evaluate the efficacy of Gokshurkadi churna in the management of mutrashmari.
Null hypothesis H0 Gokshurkadi churna is not significantly effective in the management of mutrashmari 
Alternate Hypothesis H1 Gokshurkadi churna is significantly effective in the management of mutrashmari 
Study Design Simple Randomized Control Clinical Trial 
Sample size-60 
Group A Gokshurkadi churna 
Group B pashanbhed churna 
Total Duration of the Study 21 days
Mode of administration Oral route
Follow up 1st 7th 14th 21st day 
Assessment criteria 
Objective - size and site of calculus
Subjective - pain, burning micturition, hematuria
Results will be drawn as per assessment criteria and statistical analysis 

 
Close